Greater adherence and persistence with dulaglutide compared to injectable semaglutide at 6-and 12-months follow-up in US real-world data

被引:0
|
作者
Mody, R. [1 ]
Manjelievskaia, J. [2 ]
Yu, M. [1 ]
Marchlewicz, E. H. [2 ]
Malik, R. [1 ]
Zimmerman, N. M. [2 ]
Irwin, D. E. [2 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] IBM Watson Hlth, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
449
引用
收藏
页码:232 / 232
页数:1
相关论文
共 34 条
  • [31] Real World Analysis from the "Fast STEMI" Registry on Adherence and Discontinuation of Statin Therapy Within 6 Months After ST-Elevation Myocardial Infarction on First Year Follow-Up: Prognostic Impact and Predictors of Adherence
    Morena, Arianna
    Giacobbe, Federico
    Annone, Umberto
    Ravetti, Emanuele
    di Vita, Umberto
    Giannino, Giuseppe
    Troncone, Mattia
    Carmagnola, Ludovica
    Dusi, Veronica
    CIRCULATION, 2023, 148
  • [32] Comparing gene expression profiles of adults with isolated spinal tuberculosis to disseminated spinal tuberculosis identified by 18FDG-PET/CT at time of diagnosis, 6-and 12-months follow-up: classifying clinical stages of spinal tuberculosis and monitoring treatment response (Spinal TB X cohort study)
    Scherer, Julian
    Mukasa, Sandra L.
    Wolmarans, Karen
    Guler, Reto
    Kotze, Tessa
    Song, Taeksun
    Dunn, Robert
    Laubscher, Maritz
    Pape, Hans-Christoph
    Held, Michael
    Thienemann, Friedrich
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01):
  • [33] REAL-WORLD EFFECTIVENESS OF DUPILUMAB ON PATIENT-REPORTED OUTCOMES AND SYMPTOMS IN ASTHMA: 3-MONTH FOLLOW-UP DATA FROM RESPIRE, AN OBSERVATIONAL STUDY WITH PATIENTS RECRUITED FROM A US DUPILUMAB PATIENT SUPPORT PROGRAM
    Cohn, Lauren
    Zhang, Yi
    Wang, Jessie
    Chen, Chao
    Ortiz, Benjamin
    Djandji, Michel
    Zhang, Su
    Yang, Min
    Zeiger, Robert
    CHEST, 2021, 160 (04) : 29A - 30A
  • [34] Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents 2-Year Follow-Up of the Randomized TWENTE Trial
    Tandjung, Kenneth
    Sen, Hanim
    Lam, Ming Kai
    Basalus, Mounir W. Z.
    Louwerenburg, J. W.
    Stoel, Martin G.
    van Houwelingen, K. Gert
    de Man, Frits H. A. F.
    Linssen, Gerard C. M.
    Said, Salah A. M.
    Nienhuis, Mark B.
    Lowik, Marije M.
    Verhorst, Patrick M. J.
    van der Palen, Job
    von Birgelen, Clemens
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (24) : 2406 - 2416